Skip to main content
. 2017 Oct 6;8(55):94117–94128. doi: 10.18632/oncotarget.21587

Figure 2. Kaplan-Meier estimates of the survival outcomes in nasopharyngeal carcinoma patients receiving 2 cycles and 3 to 4 cycles of NAC.

Figure 2